SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-22-032347
Filing Date
2022-09-30
Accepted
2022-09-30 19:59:03
Documents
1
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2196
  Complete submission text file 0000899243-22-032347.txt   3892
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Reporting) CIK: 0000886163 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-56427 | Film No.: 221285457
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5980 HORTON STREET SUITE 405 EMERYVILLE CA 94608
Business Address 5980 HORTON STREET SUITE 405 EMERYVILLE CA 94608 858-652-1292
OmniAb, Inc. (Issuer) CIK: 0001893653 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research